English

BioNTech SE

EDGAR

BNTX Report (type unavailable) · filed 2026-09-18

Annual consolidated revenue for 2025: about EUR 2.87B, using the latest reported figures. The previous period, 2024, was about EUR 2.751B.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

2.87 billion EUR

2025 · EUR

Exact inputs and evidence

Revenue: 2869900000 EUR Source

Operating margin

-48.95%

2025 · %

Exact inputs and evidence

Operating Income: -1404900000 EUR Source
Revenue: 2869900000 EUR Source

Operating cash flow

456 million EUR

2025 · EUR

Exact inputs and evidence

Operating Cash Flow: 456000000 EUR Source

Free cash flow

281 million EUR

2025 · EUR

Exact inputs and evidence

Operating Cash Flow: 456000000 EUR Source
Capital Expenditure: 175100000 EUR Source

Cash and cash equivalents: 7.68 billion EUR 2025-12-31 Source
Exact value

7675400000 EUR
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-09-18.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2025-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
Capital expenditure: 9 of 11 periods available· newest 2025-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+4.3%

Prior period

EUR 2.75 billion

2024-01-01 – 2024-12-31
Current period

EUR 2.87 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

2869900000 − 2751100000 = 118800000 EUR

2751100000 EUR · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
2869900000 EUR · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BioNTech SE · 2025-12-31 BioNTech SE (edgar:1776985) Year-over-year change in Revenue: 118800000 EUR Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2869900000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#2384734 Filing: 000177698526000049 Input fundies:Revenue: 2751100000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#2385633 Filing: 000177698526000049
The citation records this snapshot. The page link may show a newer release later.
Net income
−EUR 470.8 million

Prior period

−EUR 665.3 million

2024-01-01 – 2024-12-31
Current period

−EUR 1.14 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

-1136100000 − -665300000 = -470800000 EUR

-665300000 EUR · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-1136100000 EUR · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BioNTech SE · 2025-12-31 BioNTech SE (edgar:1776985) Year-over-year change in Net income: -470800000 EUR Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1136100000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#3066286 Filing: 000177698526000049 Input fundies:NetIncome: -665300000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#3067166 Filing: 000177698526000049
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+119.5%

Prior period

EUR 207.7 million

2024-01-01 – 2024-12-31
Current period

EUR 456 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

456000000 − 207700000 = 248300000 EUR

207700000 EUR · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
456000000 EUR · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BioNTech SE · 2025-12-31 BioNTech SE (edgar:1776985) Year-over-year change in Operating cash flow: 248300000 EUR Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 456000000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1136107 Filing: 000177698526000049 Input fundies:OperatingCashFlow: 207700000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1136945 Filing: 000177698526000049
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-38.9%

Prior period

EUR 286.5 million

2024-01-01 – 2024-12-31
Current period

EUR 175.1 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

175100000 − 286500000 = -111400000 EUR

286500000 EUR · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
175100000 EUR · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BioNTech SE · 2025-12-31 BioNTech SE (edgar:1776985) Year-over-year change in Capital expenditure: -111400000 EUR Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 175100000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1140790 Filing: 000177698526000049 Input fundies:CapitalExpenditure: 286500000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1141663 Filing: 000177698526000049
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue EUR 2.87 billion 100% of revenue
Operating costs Derived EUR 4.27 billion 149% of revenue
Operating income −EUR 1.4 billion −49% of revenue
Tax, interest and other Derived −EUR 268.8 million −9.4% of revenue
Net income −EUR 1.14 billion −40% of revenue

Cash

Operating cash flow EUR 456 million 16% of revenue
Capital expenditure EUR 175.1 million 6.1% of revenue
Free cash flow Derived EUR 280.9 million 9.8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 199% of revenue.
2018 Operating loss: operating costs were 142% of revenue.
2019 Operating loss: operating costs were 267% of revenue.
2020 Operating loss: operating costs were 117% of revenue.
2021 54%26%19%
2022 55%19%27%
2023 Net income was higher than operating income, so the split is not drawn.
2024 Operating loss: operating costs were 148% of revenue.
2025 Operating loss: operating costs were 149% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	61598000	122875000 Derived	-61277000	24376000 Derived	-85653000	-76882000 Derived	Source 2017-01-01 – 2017-12-31: 61598000 EUR Inspect Revenue Open source 2017-01-01 – 2017-12-31: -61277000 EUR Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -85653000 EUR Inspect Net Income Open source 2017-01-01 – 2017-12-31: -52562000 EUR Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 24320000 EUR Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	127575000	181429000 Derived	-53854000	-5835000 Derived	-48019000	-88778000 Derived	Source 2018-01-01 – 2018-12-31: 127575000 EUR Inspect Revenue Open source 2018-01-01 – 2018-12-31: -53854000 EUR Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -48019000 EUR Inspect Net Income Open source 2018-01-01 – 2018-12-31: -58877000 EUR Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 29901000 EUR Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	108600000	290100000 Derived	-181500000	-2400000 Derived	-179100000	-237100000 Derived	Source 2019-01-01 – 2019-12-31: 108600000 EUR Inspect Revenue Open source 2019-01-01 – 2019-12-31: -181500000 EUR Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -179100000 EUR Inspect Net Income Open source 2019-01-01 – 2019-12-31: -198500000 EUR Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 38600000 EUR Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	482300000	564700000 Derived	-82400000	-97600000 Derived	15200000	-79500000 Derived	Source 2020-01-01 – 2020-12-31: 482300000 EUR Inspect Revenue Open source 2020-01-01 – 2020-12-31: -82400000 EUR Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 15200000 EUR Inspect Net Income Open source 2020-01-01 – 2020-12-31: -13500000 EUR Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 66000000 EUR Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	18976700000	3692900000 Derived	15283800000	4991300000 Derived	10292500000	762200000 Derived	Source 2021-01-01 – 2021-12-31: 18976700000 EUR Inspect Revenue Open source 2021-01-01 – 2021-12-31: 15283800000 EUR Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 10292500000 EUR Inspect Net Income Open source 2021-01-01 – 2021-12-31: 889700000 EUR Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 127500000 EUR Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	17310600000	4667900000 Derived	12642700000	3208300000 Derived	9434400000	13248200000 Derived	Source 2022-01-01 – 2022-12-31: 17310600000 EUR Inspect Revenue Open source 2022-01-01 – 2022-12-31: 12642700000 EUR Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 9434400000 EUR Inspect Net Income Open source 2022-01-01 – 2022-12-31: 13577400000 EUR Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 329200000 EUR Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	3819000000	3128600000 Derived	690400000	-239900000 Derived	930300000	5122000000 Derived	Source 2023-01-01 – 2023-12-31: 3819000000 EUR Inspect Revenue Open source 2023-01-01 – 2023-12-31: 690400000 EUR Inspect Operating Income Open source 2023-01-01 – 2023-12-31: 930300000 EUR Inspect Net Income Open source 2023-01-01 – 2023-12-31: 5371400000 EUR Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 249400000 EUR Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	2751100000	4065400000 Derived	-1314300000	-649000000 Derived	-665300000	-78800000 Derived	Source 2024-01-01 – 2024-12-31: 2751100000 EUR Inspect Revenue Open source 2024-01-01 – 2024-12-31: -1314300000 EUR Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -665300000 EUR Inspect Net Income Open source 2024-01-01 – 2024-12-31: 207700000 EUR Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 286500000 EUR Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	2869900000	4274800000 Derived	-1404900000	-268800000 Derived	-1136100000	280900000 Derived	Source 2025-01-01 – 2025-12-31: 2869900000 EUR Inspect Revenue Open source 2025-01-01 – 2025-12-31: -1404900000 EUR Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -1136100000 EUR Inspect Net Income Open source 2025-01-01 – 2025-12-31: 456000000 EUR Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 175100000 EUR Inspect Capital Expenditure Open source

Amounts are exact, in EUR.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

EUR 2.9B 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(EUR)	Source evidence
20172017-12-31	Revenue	61598000	Revenue: 61598000 Open source
20182018-12-31	Revenue	127575000	Revenue: 127575000 Open source
20192019-12-31	Revenue	108600000	Revenue: 108600000 Open source
20202020-12-31	Revenue	482300000	Revenue: 482300000 Open source
20212021-12-31	Revenue	18976700000	Revenue: 18976700000 Open source
20222022-12-31	Revenue	17310600000	Revenue: 17310600000 Open source
20232023-12-31	Revenue	3819000000	Revenue: 3819000000 Open source
20242024-12-31	Revenue	2751100000	Revenue: 2751100000 Open source
20252025-12-31	Revenue	2869900000	Revenue: 2869900000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

4.3% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 61598000 Open source
20182018-12-31	Year over year	107.1%	Revenue: 127575000 Open source Revenue: 61598000 Open source
20192019-12-31	Year over year	-14.9%	Revenue: 108600000 Open source Revenue: 127575000 Open source
20202020-12-31	Year over year	344.1%	Revenue: 482300000 Open source Revenue: 108600000 Open source
20212021-12-31	Year over year	3,834.6%	Revenue: 18976700000 Open source Revenue: 482300000 Open source
20222022-12-31	Year over year	-8.8%	Revenue: 17310600000 Open source Revenue: 18976700000 Open source
20232023-12-31	Year over year	-77.9%	Revenue: 3819000000 Open source Revenue: 17310600000 Open source
20242024-12-31	Year over year	-28%	Revenue: 2751100000 Open source Revenue: 3819000000 Open source
20252025-12-31	Year over year	4.3%	Revenue: 2869900000 Open source Revenue: 2751100000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -49% 2025

Net margin -39.6% 2025

Free cash flow margin 9.8% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-99.5%	Operating Income: -61277000 Open source Revenue: 61598000 Open source
20182018-12-31	Operating margin	-42.2%	Operating Income: -53854000 Open source Revenue: 127575000 Open source
20192019-12-31	Operating margin	-167.1%	Operating Income: -181500000 Open source Revenue: 108600000 Open source
20202020-12-31	Operating margin	-17.1%	Operating Income: -82400000 Open source Revenue: 482300000 Open source
20212021-12-31	Operating margin	80.5%	Operating Income: 15283800000 Open source Revenue: 18976700000 Open source
20222022-12-31	Operating margin	73%	Operating Income: 12642700000 Open source Revenue: 17310600000 Open source
20232023-12-31	Operating margin	18.1%	Operating Income: 690400000 Open source Revenue: 3819000000 Open source
20242024-12-31	Operating margin	-47.8%	Operating Income: -1314300000 Open source Revenue: 2751100000 Open source
20252025-12-31	Operating margin	-49%	Operating Income: -1404900000 Open source Revenue: 2869900000 Open source
20172017-12-31	Net margin	-139.1%	Net Income: -85653000 Open source Revenue: 61598000 Open source
20182018-12-31	Net margin	-37.6%	Net Income: -48019000 Open source Revenue: 127575000 Open source
20192019-12-31	Net margin	-164.9%	Net Income: -179100000 Open source Revenue: 108600000 Open source
20202020-12-31	Net margin	3.2%	Net Income: 15200000 Open source Revenue: 482300000 Open source
20212021-12-31	Net margin	54.2%	Net Income: 10292500000 Open source Revenue: 18976700000 Open source
20222022-12-31	Net margin	54.5%	Net Income: 9434400000 Open source Revenue: 17310600000 Open source
20232023-12-31	Net margin	24.4%	Net Income: 930300000 Open source Revenue: 3819000000 Open source
20242024-12-31	Net margin	-24.2%	Net Income: -665300000 Open source Revenue: 2751100000 Open source
20252025-12-31	Net margin	-39.6%	Net Income: -1136100000 Open source Revenue: 2869900000 Open source
20172017-12-31	Free cash flow margin	-124.8%	Revenue: 61598000 Open source Operating Cash Flow: -52562000 Open source Capital Expenditure: 24320000 Open source
20182018-12-31	Free cash flow margin	-69.6%	Revenue: 127575000 Open source Operating Cash Flow: -58877000 Open source Capital Expenditure: 29901000 Open source
20192019-12-31	Free cash flow margin	-218.3%	Revenue: 108600000 Open source Operating Cash Flow: -198500000 Open source Capital Expenditure: 38600000 Open source
20202020-12-31	Free cash flow margin	-16.5%	Revenue: 482300000 Open source Operating Cash Flow: -13500000 Open source Capital Expenditure: 66000000 Open source
20212021-12-31	Free cash flow margin	4%	Revenue: 18976700000 Open source Operating Cash Flow: 889700000 Open source Capital Expenditure: 127500000 Open source
20222022-12-31	Free cash flow margin	76.5%	Revenue: 17310600000 Open source Operating Cash Flow: 13577400000 Open source Capital Expenditure: 329200000 Open source
20232023-12-31	Free cash flow margin	134.1%	Revenue: 3819000000 Open source Operating Cash Flow: 5371400000 Open source Capital Expenditure: 249400000 Open source
20242024-12-31	Free cash flow margin	-2.9%	Revenue: 2751100000 Open source Operating Cash Flow: 207700000 Open source Capital Expenditure: 286500000 Open source
20252025-12-31	Free cash flow margin	9.8%	Revenue: 2869900000 Open source Operating Cash Flow: 456000000 Open source Capital Expenditure: 175100000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

EUR 456M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(EUR)	Source evidence
20172017-12-31	Operating cash flow	-52562000	Operating Cash Flow: -52562000 Open source
20182018-12-31	Operating cash flow	-58877000	Operating Cash Flow: -58877000 Open source
20192019-12-31	Operating cash flow	-198500000	Operating Cash Flow: -198500000 Open source
20202020-12-31	Operating cash flow	-13500000	Operating Cash Flow: -13500000 Open source
20212021-12-31	Operating cash flow	889700000	Operating Cash Flow: 889700000 Open source
20222022-12-31	Operating cash flow	13577400000	Operating Cash Flow: 13577400000 Open source
20232023-12-31	Operating cash flow	5371400000	Operating Cash Flow: 5371400000 Open source
20242024-12-31	Operating cash flow	207700000	Operating Cash Flow: 207700000 Open source
20252025-12-31	Operating cash flow	456000000	Operating Cash Flow: 456000000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

EUR 280.9M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(EUR)	Source evidence
20172017-12-31	Free cash flow	-76882000	Operating Cash Flow: -52562000 Open source Capital Expenditure: 24320000 Open source
20182018-12-31	Free cash flow	-88778000	Operating Cash Flow: -58877000 Open source Capital Expenditure: 29901000 Open source
20192019-12-31	Free cash flow	-237100000	Operating Cash Flow: -198500000 Open source Capital Expenditure: 38600000 Open source
20202020-12-31	Free cash flow	-79500000	Operating Cash Flow: -13500000 Open source Capital Expenditure: 66000000 Open source
20212021-12-31	Free cash flow	762200000	Operating Cash Flow: 889700000 Open source Capital Expenditure: 127500000 Open source
20222022-12-31	Free cash flow	13248200000	Operating Cash Flow: 13577400000 Open source Capital Expenditure: 329200000 Open source
20232023-12-31	Free cash flow	5122000000	Operating Cash Flow: 5371400000 Open source Capital Expenditure: 249400000 Open source
20242024-12-31	Free cash flow	-78800000	Operating Cash Flow: 207700000 Open source Capital Expenditure: 286500000 Open source
20252025-12-31	Free cash flow	280900000	Operating Cash Flow: 456000000 Open source Capital Expenditure: 175100000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

12.6% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2017-12-31	Liabilities / assets	Not reported	No source recorded
20182018-12-31	Liabilities / assets	59.1%	Total Liabilities: 385986000 Open source Total Assets: 652986000 Open source
20192019-12-31	Liabilities / assets	38.1%	Total Liabilities: 304155000 Open source Total Assets: 797647000 Open source
20202020-12-31	Liabilities / assets	40.8%	Total Liabilities: 946800000 Open source Total Assets: 2318600000 Open source
20212021-12-31	Liabilities / assets	24.9%	Total Liabilities: 3937100000 Open source Total Assets: 15830800000 Open source
20222022-12-31	Liabilities / assets	13.8%	Total Liabilities: 3223500000 Open source Total Assets: 23279100000 Open source
20232023-12-31	Liabilities / assets	12%	Total Liabilities: 2760400000 Open source Total Assets: 23006300000 Open source
20242024-12-31	Liabilities / assets	13.8%	Total Liabilities: 3118600000 Open source Total Assets: 22529700000 Open source
20252025-12-31	Liabilities / assets	12.6%	Total Liabilities: 2764400000 Open source Total Assets: 21988600000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

7.54× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2017-12-31	Current assets / current liabilities	Not reported	No source recorded
20182018-12-31	Current assets / current liabilities	3.56×	Current Assets: 448961000 Open source Current Liabilities: 126121000 Open source
20192019-12-31	Current assets / current liabilities	4.05×	Current Assets: 560151000 Open source Current Liabilities: 138142000 Open source
20202020-12-31	Current assets / current liabilities	2.75×	Current Assets: 1666900000 Open source Current Liabilities: 606000000 Open source
20212021-12-31	Current assets / current liabilities	4.33×	Current Assets: 15072300000 Open source Current Liabilities: 3481600000 Open source
20222022-12-31	Current assets / current liabilities	7.43×	Current Assets: 21922000000 Open source Current Liabilities: 2950600000 Open source
20232023-12-31	Current assets / current liabilities	9.43×	Current Assets: 19527300000 Open source Current Liabilities: 2070500000 Open source
20242024-12-31	Current assets / current liabilities	7.45×	Current Assets: 18803500000 Open source Current Liabilities: 2523200000 Open source
20252025-12-31	Current assets / current liabilities	7.54×	Current Assets: 16146600000 Open source Current Liabilities: 2142300000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−EUR 85.65 million Exact value Exact value: -85653000 EUR 2017-01-01 – 2017-12-31: -85653000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · BioNTech SE · 2017-12-31 BioNTech SE (edgar:1776985) Net Income: -85653000 EUR Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -85653000 EUR (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312520092985/bntx-20191231.xml#370055 Filing: 000119312520092985 The citation records this snapshot. The page link may show a newer release later.	−EUR 52.56 million Exact value Exact value: -52562000 EUR 2017-01-01 – 2017-12-31: -52562000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BioNTech SE · 2017-12-31 BioNTech SE (edgar:1776985) Operating Cash Flow: -52562000 EUR Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -52562000 EUR (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312520092985/bntx-20191231.xml#406855 Filing: 000119312520092985 The citation records this snapshot. The page link may show a newer release later.	EUR 24.32 million Exact value Exact value: 24320000 EUR 2017-01-01 – 2017-12-31: 24320000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BioNTech SE · 2017-12-31 BioNTech SE (edgar:1776985) Capital Expenditure: 24320000 EUR Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 24320000 EUR (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312520092985/bntx-20191231.xml#407586 Filing: 000119312520092985 The citation records this snapshot. The page link may show a newer release later.	−EUR 76.88 million Calculation and evidence -52562000 − 24320000 EUR Exact free cash flow: -76882000 EUR 2017-01-01 – 2017-12-31: -52562000 EUR · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 24320000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BioNTech SE · 2017-12-31 BioNTech SE (edgar:1776985) Free cash flow: -76882000 EUR Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -52562000 EUR (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312520092985/bntx-20191231.xml#406855 Filing: 000119312520092985 Input fundies:CapitalExpenditure: 24320000 EUR (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312520092985/bntx-20191231.xml#407586 Filing: 000119312520092985 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−EUR 48.02 million Exact value Exact value: -48019000 EUR 2018-01-01 – 2018-12-31: -48019000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · BioNTech SE · 2018-12-31 BioNTech SE (edgar:1776985) Net Income: -48019000 EUR Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -48019000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000156459021016723/bntx-20201231.xml#481421 Filing: 000156459021016723 The citation records this snapshot. The page link may show a newer release later.	−EUR 58.88 million Exact value Exact value: -58877000 EUR 2018-01-01 – 2018-12-31: -58877000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BioNTech SE · 2018-12-31 BioNTech SE (edgar:1776985) Operating Cash Flow: -58877000 EUR Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -58877000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000156459021016723/bntx-20201231.xml#520632 Filing: 000156459021016723 The citation records this snapshot. The page link may show a newer release later.	EUR 29.9 million Exact value Exact value: 29901000 EUR 2018-01-01 – 2018-12-31: 29901000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BioNTech SE · 2018-12-31 BioNTech SE (edgar:1776985) Capital Expenditure: 29901000 EUR Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 29901000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000156459021016723/bntx-20201231.xml#521366 Filing: 000156459021016723 The citation records this snapshot. The page link may show a newer release later.	−EUR 88.78 million Calculation and evidence -58877000 − 29901000 EUR Exact free cash flow: -88778000 EUR 2018-01-01 – 2018-12-31: -58877000 EUR · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 29901000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BioNTech SE · 2018-12-31 BioNTech SE (edgar:1776985) Free cash flow: -88778000 EUR Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -58877000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000156459021016723/bntx-20201231.xml#520632 Filing: 000156459021016723 Input fundies:CapitalExpenditure: 29901000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000156459021016723/bntx-20201231.xml#521366 Filing: 000156459021016723 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−EUR 179.1 million Exact value Exact value: -179100000 EUR 2019-01-01 – 2019-12-31: -179100000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · BioNTech SE · 2019-12-31 BioNTech SE (edgar:1776985) Net Income: -179100000 EUR Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -179100000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000095017022020213/bntx-20211231.htm#8186045 Filing: 000095017022020213 The citation records this snapshot. The page link may show a newer release later.	−EUR 198.5 million Exact value Exact value: -198500000 EUR 2019-01-01 – 2019-12-31: -198500000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BioNTech SE · 2019-12-31 BioNTech SE (edgar:1776985) Operating Cash Flow: -198500000 EUR Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -198500000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000095017022020213/bntx-20211231.htm#6381239 Filing: 000095017022020213 The citation records this snapshot. The page link may show a newer release later.	EUR 38.6 million Exact value Exact value: 38600000 EUR 2019-01-01 – 2019-12-31: 38600000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BioNTech SE · 2019-12-31 BioNTech SE (edgar:1776985) Capital Expenditure: 38600000 EUR Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 38600000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000095017022020213/bntx-20211231.htm#6393205 Filing: 000095017022020213 The citation records this snapshot. The page link may show a newer release later.	−EUR 237.1 million Calculation and evidence -198500000 − 38600000 EUR Exact free cash flow: -237100000 EUR 2019-01-01 – 2019-12-31: -198500000 EUR · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 38600000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BioNTech SE · 2019-12-31 BioNTech SE (edgar:1776985) Free cash flow: -237100000 EUR Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -198500000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000095017022020213/bntx-20211231.htm#6381239 Filing: 000095017022020213 Input fundies:CapitalExpenditure: 38600000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000095017022020213/bntx-20211231.htm#6393205 Filing: 000095017022020213 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	EUR 15.2 million Exact value Exact value: 15200000 EUR 2020-01-01 – 2020-12-31: 15200000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · BioNTech SE · 2020-12-31 BioNTech SE (edgar:1776985) Net Income: 15200000 EUR Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=EUR&dimensions= Input fundies:NetIncome: 15200000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312523079791/d377167d20f.htm#4246926 Filing: 000119312523079791 The citation records this snapshot. The page link may show a newer release later.	−EUR 13.5 million Exact value Exact value: -13500000 EUR 2020-01-01 – 2020-12-31: -13500000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BioNTech SE · 2020-12-31 BioNTech SE (edgar:1776985) Operating Cash Flow: -13500000 EUR Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -13500000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312523079791/d377167d20f.htm#3271021 Filing: 000119312523079791 The citation records this snapshot. The page link may show a newer release later.	EUR 66 million Exact value Exact value: 66000000 EUR 2020-01-01 – 2020-12-31: 66000000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BioNTech SE · 2020-12-31 BioNTech SE (edgar:1776985) Capital Expenditure: 66000000 EUR Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 66000000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312523079791/d377167d20f.htm#3275130 Filing: 000119312523079791 The citation records this snapshot. The page link may show a newer release later.	−EUR 79.5 million Calculation and evidence -13500000 − 66000000 EUR Exact free cash flow: -79500000 EUR 2020-01-01 – 2020-12-31: -13500000 EUR · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 66000000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BioNTech SE · 2020-12-31 BioNTech SE (edgar:1776985) Free cash flow: -79500000 EUR Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13500000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312523079791/d377167d20f.htm#3271021 Filing: 000119312523079791 Input fundies:CapitalExpenditure: 66000000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000119312523079791/d377167d20f.htm#3275130 Filing: 000119312523079791 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	EUR 10.29 billion Exact value Exact value: 10292500000 EUR 2021-01-01 – 2021-12-31: 10292500000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · BioNTech SE · 2021-12-31 BioNTech SE (edgar:1776985) Net Income: 10292500000 EUR Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=EUR&dimensions= Input fundies:NetIncome: 10292500000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698524000027/bntx-20231231.htm#4202466 Filing: 000177698524000027 The citation records this snapshot. The page link may show a newer release later.	EUR 889.7 million Exact value Exact value: 889700000 EUR 2021-01-01 – 2021-12-31: 889700000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BioNTech SE · 2021-12-31 BioNTech SE (edgar:1776985) Operating Cash Flow: 889700000 EUR Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: 889700000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698524000027/bntx-20231231.htm#3505306 Filing: 000177698524000027 The citation records this snapshot. The page link may show a newer release later.	EUR 127.5 million Exact value Exact value: 127500000 EUR 2021-01-01 – 2021-12-31: 127500000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BioNTech SE · 2021-12-31 BioNTech SE (edgar:1776985) Capital Expenditure: 127500000 EUR Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 127500000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698524000027/bntx-20231231.htm#3508200 Filing: 000177698524000027 The citation records this snapshot. The page link may show a newer release later.	EUR 762.2 million Calculation and evidence 889700000 − 127500000 EUR Exact free cash flow: 762200000 EUR 2021-01-01 – 2021-12-31: 889700000 EUR · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 127500000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BioNTech SE · 2021-12-31 BioNTech SE (edgar:1776985) Free cash flow: 762200000 EUR Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 889700000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698524000027/bntx-20231231.htm#3505306 Filing: 000177698524000027 Input fundies:CapitalExpenditure: 127500000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698524000027/bntx-20231231.htm#3508200 Filing: 000177698524000027 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	EUR 9.43 billion Exact value Exact value: 9434400000 EUR 2022-01-01 – 2022-12-31: 9434400000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · BioNTech SE · 2022-12-31 BioNTech SE (edgar:1776985) Net Income: 9434400000 EUR Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=EUR&dimensions= Input fundies:NetIncome: 9434400000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698525000013/bntx-20241231.htm#14615356 Filing: 000177698525000013 The citation records this snapshot. The page link may show a newer release later.	EUR 13.58 billion Exact value Exact value: 13577400000 EUR 2022-01-01 – 2022-12-31: 13577400000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BioNTech SE · 2022-12-31 BioNTech SE (edgar:1776985) Operating Cash Flow: 13577400000 EUR Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: 13577400000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698525000013/bntx-20241231.htm#12467715 Filing: 000177698525000013 The citation records this snapshot. The page link may show a newer release later.	EUR 329.2 million Exact value Exact value: 329200000 EUR 2022-01-01 – 2022-12-31: 329200000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BioNTech SE · 2022-12-31 BioNTech SE (edgar:1776985) Capital Expenditure: 329200000 EUR Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 329200000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698525000013/bntx-20241231.htm#12473179 Filing: 000177698525000013 The citation records this snapshot. The page link may show a newer release later.	EUR 13.25 billion Calculation and evidence 13577400000 − 329200000 EUR Exact free cash flow: 13248200000 EUR 2022-01-01 – 2022-12-31: 13577400000 EUR · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 329200000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BioNTech SE · 2022-12-31 BioNTech SE (edgar:1776985) Free cash flow: 13248200000 EUR Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 13577400000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698525000013/bntx-20241231.htm#12467715 Filing: 000177698525000013 Input fundies:CapitalExpenditure: 329200000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698525000013/bntx-20241231.htm#12473179 Filing: 000177698525000013 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	EUR 930.3 million Exact value Exact value: 930300000 EUR 2023-01-01 – 2023-12-31: 930300000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · BioNTech SE · 2023-12-31 BioNTech SE (edgar:1776985) Net Income: 930300000 EUR Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=EUR&dimensions= Input fundies:NetIncome: 930300000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#3067892 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.	EUR 5.37 billion Exact value Exact value: 5371400000 EUR 2023-01-01 – 2023-12-31: 5371400000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BioNTech SE · 2023-12-31 BioNTech SE (edgar:1776985) Operating Cash Flow: 5371400000 EUR Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: 5371400000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1137661 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.	EUR 249.4 million Exact value Exact value: 249400000 EUR 2023-01-01 – 2023-12-31: 249400000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BioNTech SE · 2023-12-31 BioNTech SE (edgar:1776985) Capital Expenditure: 249400000 EUR Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 249400000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1142414 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.	EUR 5.12 billion Calculation and evidence 5371400000 − 249400000 EUR Exact free cash flow: 5122000000 EUR 2023-01-01 – 2023-12-31: 5371400000 EUR · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 249400000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BioNTech SE · 2023-12-31 BioNTech SE (edgar:1776985) Free cash flow: 5122000000 EUR Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5371400000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1137661 Filing: 000177698526000049 Input fundies:CapitalExpenditure: 249400000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1142414 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−EUR 665.3 million Exact value Exact value: -665300000 EUR 2024-01-01 – 2024-12-31: -665300000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · BioNTech SE · 2024-12-31 BioNTech SE (edgar:1776985) Net Income: -665300000 EUR Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -665300000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#3067166 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.	EUR 207.7 million Exact value Exact value: 207700000 EUR 2024-01-01 – 2024-12-31: 207700000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BioNTech SE · 2024-12-31 BioNTech SE (edgar:1776985) Operating Cash Flow: 207700000 EUR Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: 207700000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1136945 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.	EUR 286.5 million Exact value Exact value: 286500000 EUR 2024-01-01 – 2024-12-31: 286500000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BioNTech SE · 2024-12-31 BioNTech SE (edgar:1776985) Capital Expenditure: 286500000 EUR Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 286500000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1141663 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.	−EUR 78.8 million Calculation and evidence 207700000 − 286500000 EUR Exact free cash flow: -78800000 EUR 2024-01-01 – 2024-12-31: 207700000 EUR · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 286500000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BioNTech SE · 2024-12-31 BioNTech SE (edgar:1776985) Free cash flow: -78800000 EUR Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 207700000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1136945 Filing: 000177698526000049 Input fundies:CapitalExpenditure: 286500000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1141663 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−EUR 1.14 billion Exact value Exact value: -1136100000 EUR 2025-01-01 – 2025-12-31: -1136100000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · BioNTech SE · 2025-12-31 BioNTech SE (edgar:1776985) Net Income: -1136100000 EUR Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -1136100000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#3066286 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.	EUR 456 million Exact value Exact value: 456000000 EUR 2025-01-01 – 2025-12-31: 456000000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BioNTech SE · 2025-12-31 BioNTech SE (edgar:1776985) Operating Cash Flow: 456000000 EUR Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: 456000000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1136107 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.	EUR 175.1 million Exact value Exact value: 175100000 EUR 2025-01-01 – 2025-12-31: 175100000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BioNTech SE · 2025-12-31 BioNTech SE (edgar:1776985) Capital Expenditure: 175100000 EUR Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 175100000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1140790 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.	EUR 280.9 million Calculation and evidence 456000000 − 175100000 EUR Exact free cash flow: 280900000 EUR 2025-01-01 – 2025-12-31: 456000000 EUR · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 175100000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BioNTech SE · 2025-12-31 BioNTech SE (edgar:1776985) Free cash flow: 280900000 EUR Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:40:36Z Snapshot: 4fdbfa9524d705c26bf30d720abe4f45f113e7e68aea15de4a0189a47d27301f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1776985?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 456000000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1136107 Filing: 000177698526000049 Input fundies:CapitalExpenditure: 175100000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1776985/000177698526000049/bntx-20251231.htm#1140790 Filing: 000177698526000049 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

378 filings · 610 latest values · 610 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001776985, 1776985, BNTX, edgar:1776985

Also known as BioNTech SE

BioNTech SE

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation